Bristol-Myers Squibb buy Piper Sandler
Start price
23.02.26
/
50%
€51.31
Target price
23.02.27
€63.41
Performance (%)
0.10%
Price
11:27
€51.36
Summary
This prediction is currently active. Since the start of the prediction for Bristol-Myers Squibb the price has only changed by 0.10%. This prediction currently runs until 23.02.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bristol-Myers Squibb | -0.444% |
| iShares Core DAX® | -2.116% |
| iShares Nasdaq 100 | -1.132% |
| iShares Nikkei 225® | -0.658% |
| iShares S&P 500 | -1.261% |
Comments by Piper_Sandler for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $75.00 price target on the stock, up previously from $66.00.
Ratings data for BMY provided by MarketBeat